Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography

Keishi Ichikawa1, Toru Miyoshi1, Kazuhiro Osawa2

  • 1Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Medicine
|August 27, 2021
PubMed

Insights

Non-alcoholic fatty liver disease (NAFLD) is linked to higher pericoronary adipose tissue (PCAT) attenuation, indicating inflammation around heart arteries. This suggests PCAT inflammation may contribute to cardiac risks in NAFLD patients.

Area of Science:

  • Cardiology
  • Radiology
  • Hepatology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a known risk factor for cardiac mortality.
  • Pericoronary adipose tissue (PCAT) attenuation, measured by the fat attenuation index on coronary computed tomography angiography (CCTA), reflects inflammation in the arteries.
  • The relationship between NAFLD and PCAT inflammation requires further investigation.

Purpose of the Study:

  • To investigate the association between PCAT attenuation and the presence of NAFLD.
  • To determine if PCAT attenuation is an independent marker of NAFLD in patients undergoing CCTA.

Main Methods:

  • A single-center cohort study included patients undergoing CCTA for suspected coronary artery disease.
  • Patients with NAFLD (n=78) were compared to a propensity score-matched cohort without NAFLD (n=78).
  • PCAT attenuation was quantified in Hounsfield units (HU) for the left anterior descending artery and right coronary artery.

Main Results:

  • Mean PCAT attenuation was significantly higher in patients with NAFLD compared to those without.
  • Higher PCAT attenuation was independently associated with NAFLD (OR 2.912, P=.005).
  • No significant differences were found in age, BMI, or conventional cardiovascular risk factors between groups.

Conclusions:

  • NAFLD is associated with increased PCAT attenuation on CCTA.
  • This suggests that pericoronary inflammation plays a role in the elevated cardiac mortality observed in NAFLD patients.
  • PCAT attenuation may serve as a potential imaging biomarker for cardiovascular risk in NAFLD.